| Date | Time | Source | Headline | Symbol | Company |
| 04/21/2006 | 1:02PM | PR Newswire (US) | Boston Scientific Completes Combination with Guidant | NYSE:GDT | Guidant Corp |
| 04/21/2006 | 9:12AM | PR Newswire (US) | Abbott Completes Acquisition of Guidant Vascular Business | NYSE:GDT | Guidant Corp |
| 04/20/2006 | 9:00AM | PR Newswire (US) | Boston Scientific Receives FTC Antitrust Approval for its Combination with Guidant | NYSE:GDT | Guidant Corp |
| 04/11/2006 | 7:05PM | PR Newswire (US) | Standard & Poor's Announces Changes to U.S. Indices | NYSE:GDT | Guidant Corp |
| 04/11/2006 | 1:59PM | PR Newswire (US) | Boston Scientific Receives European Commission's Antitrust Clearance for Guidant Transaction | NYSE:GDT | Guidant Corp |
| 04/05/2006 | 5:34PM | PR Newswire (US) | Boston Scientific Signs Agreement Resolving All Outstanding Antitrust Issues With FTC Staff on Guidant Transaction | NYSE:GDT | Guidant Corp |
| 04/05/2006 | 5:25PM | Business Wire | Guidant Announces Preliminary First Quarter 2006 Sales | NYSE:GDT | Guidant Corp |
| 03/31/2006 | 12:03PM | PR Newswire (US) | Boston Scientific and Guidant Shareholders Each Approve Combination | NYSE:GDT | Guidant Corp |
| 03/29/2006 | 8:00AM | Business Wire | Guidant to Temporarily Suspend XIENCE V Supply; Company Expects European Launch of XIENCE V in Third Quarter 2006 | NYSE:GDT | Guidant Corp |
| 03/23/2006 | 6:10PM | PR Newswire (US) | Boston Scientific Makes Antitrust Commitments To European Commission | NYSE:GDT | Guidant Corp |
| 03/21/2006 | 7:30AM | Business Wire | Guidant Receives Independent Panel Report and Recommendations; Panel Chaired by Dr. Myerburg, an Internationally Recognized Lea | NYSE:GDT | Guidant Corp |
| 03/21/2006 | 7:25AM | PR Newswire (US) | Independent Panel Commissioned by Guidant Issues Report and Recommendations | NYSE:GDT | Guidant Corp |
| 03/20/2006 | 9:30AM | PR Newswire (US) | Institutional Shareholder Services Recommends That Shareholders of Boston Scientific and Guidant Approve Combination | NYSE:GDT | Guidant Corp |
| 03/17/2006 | 9:00AM | Business Wire | Guidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further U | NYSE:GDT | Guidant Corp |
| 03/16/2006 | 2:30PM | Business Wire | Guidant to Expand Southern California Facilities; Drug Eluting and Carotid Stents, Emerging Therapies Drive Expansion | NYSE:GDT | Guidant Corp |
| 03/15/2006 | 2:29PM | Business Wire | Guidant Completes Enrollment in Randomized U.S. Portion of Drug Eluting Stent Pivotal Trial; Large-Scale Trial Evaluating Safet | NYSE:GDT | Guidant Corp |
| 03/14/2006 | 3:58PM | Business Wire | Guidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients Suggest | NYSE:GDT | Guidant Corp |
| 03/13/2006 | 9:00AM | Business Wire | Guidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac Defibrillators | NYSE:GDT | Guidant Corp |
| 03/10/2006 | 1:00PM | Business Wire | R. Frederick McCoy, Jr., Elects Early Retirement from Guidant | NYSE:GDT | Guidant Corp |
| 03/09/2006 | 12:00PM | Business Wire | Guidant Launches Innovative Cobalt Chromium Biliary Stent; RX HERCULINK ELITE Biliary Stent System Provides Superb Deliverabili | NYSE:GDT | Guidant Corp |
| 03/09/2006 | 9:02AM | Business Wire | Guidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting Coronary | NYSE:GDT | Guidant Corp |
| 03/06/2006 | 11:14AM | PR Newswire (US) | Seven Summits Research Releases Comments on GM, RIMM, CELG, GDT, and LEXR | NYSE:GDT | Guidant Corp |
| 03/02/2006 | 6:11PM | PR Newswire (US) | Boston Scientific and Guidant Proposed Merger Registration Statement Declared Effective | NYSE:GDT | Guidant Corp |
| 02/23/2006 | 12:09PM | PR Newswire (US) | Boston Scientific Files Notification with European Commission | NYSE:GDT | Guidant Corp |
| 02/23/2006 | 8:31AM | Business Wire | Guidant Announces Completion of FDA Inspection of St. Paul Facilities; Company Reports One Inspection Observation and Reiterates | NYSE:GDT | Guidant Corp |
| 02/07/2006 | 8:00AM | Business Wire | Theregen Announces Equity Investment from Guidant Corporation to Develop Anginera(TM) Epicardial Patch | NYSE:GDT | Guidant Corp |
| 02/06/2006 | 10:32AM | PR Newswire (US) | Boston Scientific Files Hart-Scott-Rodino Pre-Merger Notification | NYSE:GDT | Guidant Corp |
| 01/30/2006 | 2:02PM | Business Wire | Guidant Receives European Approval for Drug Eluting Coronary Stent; Company Achieves CE Mark Approval Ahead of Schedule; XIENCE | NYSE:GDT | Guidant Corp |
| 01/27/2006 | 8:30AM | Business Wire | Guidant Reports Fourth Quarter Sales of $828 Million; Full Year 2005 Sales of $3.55 Billion; Earnings from Continuing Operations | NYSE:GDT | Guidant Corp |
| 01/25/2006 | 7:02AM | PR Newswire (US) | Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion | NYSE:GDT | Guidant Corp |